Ripretinib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications
Quantification of buparlisib in human liver microsomes employing an ultra-fast, sensitive UPLC-MS/MS method: in vitro and in silico metabolic stability evaluation.
Journal: The Analyst
Published: January 27, 2026
EGFR/KIT-linked proliferative bias in normal breast lobules from matched non-Hispanic Black and White women is rapidly reversible by RTK inhibition.
Journal: The American journal of pathology
Published: November 11, 2025
Gastrointestinal Stromal Tumors: Molecular Mechanisms of Drug Resistance and Advances in Therapeutic Strategies.
Journal: Journal of gastroenterology and hepatology
Published: October 19, 2025
Correction: Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS).
Journal: Frontiers in pharmacology
Published: August 20, 2025
Ultra-Fast UPLC-MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In-Silico Study for Toxic Alerts and the Metabolic Lability.
Journal: Archiv der Pharmazie
Published: August 11, 2025
Benign Keratoses With Inverted Follicular Keratosis-Like Features in a Patient Receiving Ripretinib: A Case Report.
Journal: Journal of cutaneous pathology
Published: August 09, 2025
Present management of gastrointestinal stromal tumors.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: August 05, 2025
Cerebral Metastasis of a Gastrointestinal Stromal Tumor: A Case Report and Literature Review.
Journal: Cureus
Published: June 12, 2025
Design, synthesis and biological evaluation of novel platelet-derived growth factor receptor-α (PDGFR-α) inhibitors based on 4-anilinoquinoline and 4-anilinoquinazoline scaffolds.
Journal: European journal of medicinal chemistry
Published: June 09, 2025
Last Updated: 04/28/2026